Investor Relations

Listed On The Shanghai Stock Exchange In June 2001, With A Maximum Market Value Of 47.5 Billion

Ad hoc announcement pursuant to Art. 53 LR-Announcement on the Implementation of 2026 Interim Profit Distribution of JCARE

Time:2026-10-13

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Obtaining the Drug Supplementary Application Approval Notice

Time:2026-09-29

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Resolutions of 2026 First Extraordinary General Meeting

Time:2026-09-24

Ad hoc announcement pursuant to Art. 53 LR -JCARE Announcement on the Election of a Non-independent Director

Time:2026-09-18

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on the Additional Ad Hoc Proposal for the 2026 First Extraordinary General Meeting

Time:2026-09-11

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Change of Chairman and Adjustment of Members of Board Committees

Time:2026-09-11

Ad hoc announcement pursuant to Art. 53 LR-JCARE Notice of 2026 First Extraordinary General Meeting

Time:2026-09-04

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on the Proposed 2026 Interim Profit Distribution Plan of the Company

Time:2026-09-04

Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Obtaining the Drug Registration Certificate

Time:2026-08-27

Ad hoc announcement pursuant to Art. 53 JCARE 2026 Interim Report

Time:2026-08-24

< 1234...16 >